Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients

Journal of Cardiac Failure

Volumn 10, Issue 6, 2004, Pages 496-502

  De Matos, Luciana D N J ^a   Gardenghi, Giulliano ^a   Rondon, Maria Urbana P B ^a   Soufen, Helena N ^a   Tirone, Adriana P ^a   Barretto, Antonio C P ^a   Brum, Patrícia C ^a   Middlekauff, Holly R ^b   Negrão, Carlos E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blocker; exercise; forearm vascular resistance; Neurovascular control

Indexed keywords

CARVEDILOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; FOREARM; HEART FAILURE; HEART RATE; HUMAN; ISOMETRIC EXERCISE; LONG TERM CARE; MALE; MUSCLE BLOOD FLOW; NERVE CONDUCTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REST; SYMPATHETIC NERVE; SYMPATHETIC TONE; VASCULAR RESISTANCE; CONGESTIVE HEART FAILURE; DOSE RESPONSE; EXERCISE TEST; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY; PERONEUS NERVE; PHYSIOLOGY; SKELETAL MUSCLE; BLOOD PRESSURE MONITORING; MUSCLE CONTRACTION; RANDOMIZATION; RECEPTOR BLOCKING;

ADRENERGIC BETA-ANTAGONISTS; BLOOD PRESSURE; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERONEAL NERVE; PROPANOLAMINES; VASCULAR RESISTANCE;

EID: 10344227688     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.03.006     Document Type: Article

References (34)

1. Eichhorn E.J., Bristow M.R. Medical therapy can improve the biologic properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation. 94:1996;2285-2296
2. Bristow M.R., Roden R.L., Lowes B.D., Gilbert E.M., Eichhorn E.J. The role of third generation β-blocking agents in chronic heart failure. Clin Cardiol. 21:1998;I-3-I-13
3. Bristow M.R. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol. 80:1997;26L-40L
4. Hall A.S., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., Eichhorn E.J. Time course of improvement in left ventricular function, mass, and geometry in patients with congestive heart failure treated with β-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161
5. Foody J.M., Farrell M.H., Krumholz H.M. β-blocker therapy in heart failure. JAMA. 287:2002;883-889
6. Bristow M.R., Gilbert E.M., Abraham W.T., Adams K.F., Fowler M.B., Hershberger R.E., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 94:1996;2807-2816
7. Gaffiney T.E., Braunwald E. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med. 34:1963;320-324
8. Bristow M.R., Ginsburg R., Minobe W.A., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med. 307:1982;205-211
9. Swedberg K., Viquerat C., Rouleau J.L., Roizen M., Atherton B., Parmley W.W., et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol. 54:1984;783-786
10. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 73:1986;615-621
11. Bristow M.R., Kantrowitz N.E., Ginsburg R., Fowler M.B. β-Adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol. 17:1985;41-52
12. Poole-Wilson P.A., Swedberg K., Cleland J.G.F., Di Lenarda A., Hanrath P., Komajda M., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial. Lancet. 362:2003;7-13
13. White M., Wiechmann R.J., Roden R.L., Hagan M.B., Wollmering M.M., Port J.D., et al. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury: evidence for catecholamine-mediated myocardial damage. Circulation. 92:1995;2183-2189
14. Imperato-McGinley F., Gautier T., Ehlers K., Zullo M.A., Goldstein D.S., Vaughan E.D., et al. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med. 316:1987;793-797
15. Rahman M.A., Hara K., Daly P.A., Wigle E.D., Floras J.S. Reductions in muscle sympathetic nerve activity after long term metoprolol for dilated cardiomyopathy: preliminary observations. Br Heart J. 74:1995;431-436
16. Azevedo E.R., Kubo T., Mak S., Al-Hesayen A., Schofield A., Allan R., et al. Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity. Circulation. 104:2001;2194-2199
17. Cohen-Solal A. Cardiopulmonary exercise testing in chronic heart failure. Wasserman K. Exercise gas exchange in heart disease. 1996;17-38 Futura Publishing Company, Armonk (NY)
18. Valbo A.B., Hagbarth K.E., Torebjork H.E., Wallin B.G. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev. 59:1979;919-957
19. Delius W., Hagbarth K.E., Hongel A., Wallin B.G. Maneuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand. 84:1972;82-94
20. Negrão C.E., Rondon M.U.P.B., Tinucci T., Alves M.J.N., Roveda F., Braga A.M.W., et al. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol. 280:2001;H1286-H1292
21. Roveda F., Middlekauff H.R., Rondon M.U.P.B., Reis S.F., Souza M., Nastari L., et al. The effects of exercise training on sympathetic neural activation in advanced heart failure. J Am Coll Cardiol. 42:2003;854-860
22. Fagius J., Wallin B.G. Long-term variability and reproducibility of human muscle nerve activity at rest, as reassessed after a decade. Clin Auton Res. 3:1993;201-205
23. Middlekauff H.R., Nguyen A.H., Negrão C.E., Nitzschi E.U., Hoh C.K., Natterson B.A., et al. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure. Circulation. 96:1997;1835-1842
24. Middlekauff H.R. Mechanisms and implications of autonomic nervous system dysfunction in heart failure. Curr Opin Cardiol. 12:1997;265-275
25. Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 26:1994;335-346
26. Ruffolo R.R. Jr., Boyle D.A., Venuti R.P., Lukas M.A. Preclinical and clinical pharmacology of carvedilol. J Hum Hypertens. 7:(Suppl 1):1993;S2-S15
27. Hirsch A.T., Dzau V.J., Creager M.A. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. Circulation. 75:(Suppl. IV):1987;36-48
28. Barreto-Filho J.A.S., Consolim-Colombo F.M., Lopes H.F., Sobrinho C.R.M., Guerra-Riccio G.M., Krieger E.M. Dysregulation of peripheral and central chemoreflex responses in Chagas' heart disease patients without heart failure. Circulation. 104:2001;1792-1798
29. Ribeiro M.M., Trombetta I.C., Batalha L.T., Rondon M.U.P.B., Forjaz C.L.M., Barretto A.C.P., et al. Muscle sympathetic nerve activity and hemodynamic alterations in middle-aged obese women. Braz J Med Biol Res. 34:2001;475-478
30. 1-adrenoceptor blockade during long-term treatment of heart failure with carvedilol. J Am Coll Cardiol. 38:2001;1463-1469
31. Eklund B., Kaijser L. Effect of regional alpha- and beta- adrenergic blockade on blood flow in the resting forearm during contralateral isometric handgrip. J Physiol. 26:1976;39-50
32. Joyner M.J., Halliwill J.R. Sympathetic vasodilatation in human limbs. J Physiol. 526:2000;471-480
33. Reed A.S., Tschakovsky M.E., Mixson C.T., Halliwill J.R., Torp K.D., Nauss L.A., et al. Skeletal muscle vasodilation during sympathoexcitation is not neurally mediated in humans. J Physiol. 525:2000;253-262
34. Magnusson G., Kaijser C., Sylvén C., Karlberg K.E., Isberg B., Saltin B. Peak skeletal muscle perfusion is maintained in patients with chronic heart failure when only a small muscle mass is exercised. Cardiovascular Res. 33:1997;297-306